TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant ...
EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H’28 ...
I’m starting to believe that Conservative Leader Pierre Poilievre is the subject of an elaborate, prolonged hazing ritual.
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
(Bloomberg Businessweek) -- When most people think of golf, their mind goes immediately to grass. If they picture sand at all, they think of the place they don’t want their shot to land. But to a ...
Keep the news in the Wayback Machine. Sign Fight for the Future's letter. Please Don't Scroll Past This Can you chip in? The Internet Archive partners with libraries, archives, and institutions across ...
Seam makes it easy to integrate IoT devices with your applications. This is an official SDK for the Seam API. Please refer to the official Seam Docs to get started. The SDK is fully tree-shakeable and ...
At the same time, VIS-101 is also an important driver, and I apologise for now focusing on it too much. It provides a second leg to the story here, with a Phase 2b initiation expected sometime in 2H26 ...
Secure Ad Serving (HTTPS): All third-party served creatives and their components (images, stylesheets, JavaScript, tracking pixels, etc.) must be secure (HTTPS) to ensure compliance and correct ...